[The effect of clonidine on the duration of vecuronium-induced neuromuscular blockade in humans]. 1995

T Nakahara, and T Akazawa, and Y Kinoshita, and J Nozaki
Department of Anesthesia, Tokushima Municipal Hospital.

The clinical duration of a bolus of vecuronium 0.1 mg.kg-1 was measured in two groups of patients between 31-55 years of age undergoing elective general surgery. Eight patients received no premedication and eight others clondine 4.0-5.5 micrograms.kg-1 orally 90 minutes before arriving at the operating room. Neuromuscular blockade was continuously quantitated by recording the acceleration response to stimulation of the ulnar nerve train-of-four. Anesthesia was induced with thiamylal 5 mg.kg-1 and maintained with 50% nitrous oxide and isoflurane (Fet 0.5%) in oxygen. Supplementary doses of fentanyl (2 micrograms.kg-1 for the control group and 1 microgram.kg-1 for the clonidine group) were given before intubation and when anesthesia was considered to be insufficient. The clinical duration of vecuronium, defined as recovery to 25% of the control first twitch in the train-of-four sequence, was significantly longer in the clonidine group (51.2 +/- 7.5 minutes compared with 40.5 +/- 5.1 minutes in the control group, P < 0.01). In the duration of blockade there were no significant differences between groups for mean SBP, DBP and HR. Patients in the clonidine group required significantly less fentanyl to maintain hemodynamic stability. We conclude that clonidine prolongs the clinical duration of vecuronium by 26.4%, most probably by a pharmacokinetic interaction.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009469 Neuromuscular Junction The synapse between a neuron and a muscle. Myoneural Junction,Nerve-Muscle Preparation,Junction, Myoneural,Junction, Neuromuscular,Junctions, Myoneural,Junctions, Neuromuscular,Myoneural Junctions,Nerve Muscle Preparation,Nerve-Muscle Preparations,Neuromuscular Junctions,Preparation, Nerve-Muscle,Preparations, Nerve-Muscle
D011229 Preanesthetic Medication Drugs administered before an anesthetic to decrease a patient's anxiety and control the effects of that anesthetic. Medication, Preanesthetic,Medications, Preanesthetic,Preanesthetic Medications
D003000 Clonidine An imidazoline sympatholytic agent that stimulates ALPHA-2 ADRENERGIC RECEPTORS and central IMIDAZOLINE RECEPTORS. It is commonly used in the management of HYPERTENSION. Catapres,Catapresan,Catapressan,Chlophazolin,Clofelin,Clofenil,Clonidine Dihydrochloride,Clonidine Hydrochloride,Clonidine Monohydrobromide,Clonidine Monohydrochloride,Clopheline,Dixarit,Gemiton,Hemiton,Isoglaucon,Klofelin,Klofenil,M-5041T,ST-155,Dihydrochloride, Clonidine,Hydrochloride, Clonidine,M 5041T,M5041T,Monohydrobromide, Clonidine,Monohydrochloride, Clonidine,ST 155,ST155
D003473 Neuromuscular Nondepolarizing Agents Drugs that interrupt transmission at the skeletal neuromuscular junction without causing depolarization of the motor end plate. They prevent acetylcholine from triggering muscle contraction and are used as muscle relaxants during electroshock treatments, in convulsive states, and as anesthesia adjuvants. Curare-Like Agents,Curariform Drugs,Muscle Relaxants, Non-Depolarizing,Neuromuscular Blocking Agents, Competitive,Nondepolarizing Blockers,Agents, Curare-Like,Agents, Neuromuscular Nondepolarizing,Blockers, Nondepolarizing,Curare Like Agents,Drugs, Curariform,Muscle Relaxants, Non Depolarizing,Non-Depolarizing Muscle Relaxants,Nondepolarizing Agents, Neuromuscular
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations

Related Publications

T Nakahara, and T Akazawa, and Y Kinoshita, and J Nozaki
August 1999, Anaesthesia and intensive care,
T Nakahara, and T Akazawa, and Y Kinoshita, and J Nozaki
August 1998, Anaesthesia and intensive care,
T Nakahara, and T Akazawa, and Y Kinoshita, and J Nozaki
May 1989, Anaesthesia,
T Nakahara, and T Akazawa, and Y Kinoshita, and J Nozaki
March 1990, Anesthesia and analgesia,
T Nakahara, and T Akazawa, and Y Kinoshita, and J Nozaki
July 1994, Acta anaesthesiologica Scandinavica,
T Nakahara, and T Akazawa, and Y Kinoshita, and J Nozaki
October 1991, Canadian journal of anaesthesia = Journal canadien d'anesthesie,
T Nakahara, and T Akazawa, and Y Kinoshita, and J Nozaki
April 1995, Masui. The Japanese journal of anesthesiology,
T Nakahara, and T Akazawa, and Y Kinoshita, and J Nozaki
December 1988, Anesthesiology,
T Nakahara, and T Akazawa, and Y Kinoshita, and J Nozaki
May 1993, Anesthesiology,
Copied contents to your clipboard!